<p>James Flanegan of the University of Florida in the U.S. proposes to develop a non-infectious poliovirus vaccine using encapsidated replicons or mature empty capsids that retain full immunogenicity. Either approach can be potentially used to develop a new vaccine that can be safely used in a pre- or post-eradication world.</p>


James Flanegan of the University of Florida in the U.S. proposes to develop a non-infectious poliovirus vaccine using encapsidated replicons or mature empty capsids that retain full immunogenicity. Either approach can be potentially used to develop a new vaccine that can be safely used in a pre- or post-eradication world.